ID

28368

Description

Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT00877149

Link

https://clinicaltrials.gov/show/NCT00877149

Keywords

Versions (1)
  1. 1/8/18 1/8/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

January 8, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Compensated Chronic Hepatitis B NCT00877149

English

Eligibility Compensated Chronic Hepatitis B NCT00877149

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient completed study cldt600acn04 study and will be available to immediately rollover into this study without discontinuation of study drug.
Description

Study Subject Participation Status | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
patient was not discontinued from the previous cldt600acn04 study.
Description

Absence Patient withdrawn from trial

Data type

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0422727
adult patients with chb (hbeag positive or hbeag negative).
Description

Hepatitis B, Chronic | Hepatitis B e antigen positive | Hepatitis B e antigen negative

Data type

boolean

Alias
UMLS CUI [1]
C0524909
UMLS CUI [2]
C0392390
UMLS CUI [3]
C0948827
hbv dna pcr undetectable in recent 12 months.
Description

Hbv DNA Test PCR Negative

Data type

boolean

Alias
UMLS CUI [1,1]
C1256114
UMLS CUI [1,2]
C0032520
UMLS CUI [1,3]
C1513916
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or breastfeeding, or has plan of pregnant during study period.
Description

Pregnancy | Breast Feeding | Pregnancy, Planned

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
patient is co-infected with hepatitis c virus (hcv), hepatitis d virus (hdv), or hiv at screening visit.
Description

HCV coinfection | Coinfection Hepatitis Delta Virus | HIV coinfection

Data type

boolean

Alias
UMLS CUI [1]
C1698259
UMLS CUI [2,1]
C0275524
UMLS CUI [2,2]
C0011220
UMLS CUI [3]
C4062778
patient has received within the past 12 months any anti-hbv treatment combination (add-on therapy) or switch to other anti hbv treatment from telbivudine at investigator's discretion.
Description

Combined Modality Therapy Anti-hepatitis B (HBV) Agents | telbivudine

Data type

boolean

Alias
UMLS CUI [1,1]
C0009429
UMLS CUI [1,2]
C4020577
UMLS CUI [2]
C1453933
other protocol-defined inclusion/exclusion criteria may apply.
Description

Eligibility Criteria Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Back to the top of the page

Similar models

Eligibility Compensated Chronic Hepatitis B NCT00877149

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Study Subject Participation Status | Investigational New Drugs
Item
patient completed study cldt600acn04 study and will be available to immediately rollover into this study without discontinuation of study drug.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Absence Patient withdrawn from trial
Item
patient was not discontinued from the previous cldt600acn04 study.
boolean
C0332197 (UMLS CUI [1,1])
C0422727 (UMLS CUI [1,2])
Hepatitis B, Chronic | Hepatitis B e antigen positive | Hepatitis B e antigen negative
Item
adult patients with chb (hbeag positive or hbeag negative).
boolean
C0524909 (UMLS CUI [1])
C0392390 (UMLS CUI [2])
C0948827 (UMLS CUI [3])
Hbv DNA Test PCR Negative
Item
hbv dna pcr undetectable in recent 12 months.
boolean
C1256114 (UMLS CUI [1,1])
C0032520 (UMLS CUI [1,2])
C1513916 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
pregnant or breastfeeding, or has plan of pregnant during study period.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
HCV coinfection | Coinfection Hepatitis Delta Virus | HIV coinfection
Item
patient is co-infected with hepatitis c virus (hcv), hepatitis d virus (hdv), or hiv at screening visit.
boolean
C1698259 (UMLS CUI [1])
C0275524 (UMLS CUI [2,1])
C0011220 (UMLS CUI [2,2])
C4062778 (UMLS CUI [3])
Combined Modality Therapy Anti-hepatitis B (HBV) Agents | telbivudine
Item
patient has received within the past 12 months any anti-hbv treatment combination (add-on therapy) or switch to other anti hbv treatment from telbivudine at investigator's discretion.
boolean
C0009429 (UMLS CUI [1,1])
C4020577 (UMLS CUI [1,2])
C1453933 (UMLS CUI [2])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial